Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis

Long‐term follow‐up of 27 patients with hepatitis B virus—related chronic liver disease treated by transplantation showed that 23 had hepatitis B virus recurrence. In 13 patients late changes in the grafts were similar to those described in other series: minor abnormalities in five cases, chronic active hepatitis in five cases and non‐hepatitis B virus—related graft dysfunction in three cases. Three patients had incomplete histological follow‐up. Analysis of the histological changes and viral antigen expression in six cases revealed a distinct and novel pattern termed fibrosing cholestatic hepatitis. Development of fibrosing cholestatic hepatitis was associated with rapidly progressive graft dysfunction. It is postulated that this pattern of fibrosing cholestatic hepatitis develops because of a high cytoplasmic expression of viral antigens, including HBsAg. The remaining case had some features of fibrosing cholestatic hepatitis. The main histological features of this unique syndrome include thin, perisinusoidal bands of fibrosis extending from portal tracts to surround plates of ductular‐type epithelium; prominent cholestasis; ground‐glass transformation; and ballooning of hepatocytes with cell loss and mild mixed inflammatory reaction. (HEPATOLOGY 1991;13:150–157).

[1]  G. Alexander,et al.  Detection of hepatitis B virus antigens in liver tissue. A relation to viral replication and histology in chronic hepatitis B infection. , 1990, Gastroenterology.

[2]  G. Alexander,et al.  Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. , 1989, The Quarterly journal of medicine.

[3]  M. Castagneto,et al.  Results of liver transplantation for hepatitis delta disease without immunoprophylaxis. , 1989, Transplantation proceedings.

[4]  B. Gridelli,et al.  Long-term results after liver transplantation in B and delta hepatitis. , 1989, Transplantation proceedings.

[5]  D. Samuel,et al.  Graft hepatitis delta virus reinfection after orthotopic liver transplantation in HDV cirrhosis. , 1989, Transplantation proceedings.

[6]  V. Desmet,et al.  A cytokeratin immunohistochemical study of alcoholic liver disease: evidence that hepatocytes can express ‘bile duct‐type’ cytokeratins , 1988, Histopathology.

[7]  H. Hsu,et al.  Correlation of hepatocyte HBsAg expression with virus replication and liver pathology , 1988, Hepatology.

[8]  R. Palmiter,et al.  Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[9]  F. Negro,et al.  LIVER TRANSPLANTATION IN HEPATITIS DELTA VIRUS DISEASE , 1987, The Lancet.

[10]  R. Pichlmayr,et al.  Long-term immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts. , 1987, Transplantation proceedings.

[11]  T. Starzl,et al.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. , 1986, The American journal of pathology.

[12]  S. Tomlanovich,et al.  Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months. , 1986, Transplantation proceedings.

[13]  R. Burk,et al.  Hepatitis B virus DNA contains a glucocorticoid-responsive element. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R Williams,et al.  T lymphocyte sensitization to hbcag and T cell‐mediated unresponsiveness to HBsAg in hepatitis B virus‐related chronic liver disease , 1985, Hepatology.

[15]  J. Najarian,et al.  Orthotopic Liver Transplantation: A Pathological Study of 63 Serial Liver Biopsies from 17 Patients with Special Reference to the Diagnostic Features and Natural History of Rejection , 1984, Hepatology.

[16]  D. Vergani,et al.  Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes. , 1982, Journal of immunology.

[17]  S. Tseng,et al.  Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studies , 1982, Cell.

[18]  V. Desmet,et al.  Differential distribution of hepatitis B surface antigen and hepatitis B core antigen in the liver of hepatitis B patients. , 1976, Gastroenterology.

[19]  A. Busuttil,et al.  POLYPLOIDAL GIANT CELLS IN A LARYNGEAL BIOPSY , 1974 .

[20]  J. Juszczyk.  [Immunopathology of chronic hepatitis]. , 1973, Polskie Archiwum Medycyny Wewnetrznej.

[21]  Gerber Ma.  Immunopathology of chronic hepatitis. , 1987 .

[22]  R. Haggitt,et al.  Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. , 1986, American journal of surgery.

[23]  D. V. van Thiel,et al.  Analysis of Liver Transplantation , 1984, Hepatology.

[24]  G. Alexander,et al.  Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection , 1984, Hepatology.

[25]  T. Starzl,et al.  Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. , 1979, Archives of surgery.

[26]  K. Ishak.  Light microscopic morphology of viral hepatitis. , 1976, American journal of clinical pathology.